Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5552 participants
OBSERVATIONAL
2005-05-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* A term of whole military conscripts per year in one Reserve Force Battalion
* Military conscripts gather from all around area in Korea randomly
* Each participant undertake a chest X-ray (CXR) and blood tests including human immunodeficiency virus (HIV) at the start of initiatory training.
Exclusion Criteria
* Chest X-ray suggesting active TB
* HIV positive in serology
Design
* After giving informed consent, all participants receive one-step TST following standard procedures.
* The largest transverse diameter of induration is measured 48-72hr after injection.
* The investigator and these trained nurses were blinded to the status of their demographic characteristics.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Military Conscripts
A term of whole military conscripts per year in one Reserve Force Battalion. Military conscripts gather from all around area in Korea randomly
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Positive HIV in serology
18 Years
29 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sei Won Lee
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
HeeJin Kim, MD
Role: PRINCIPAL_INVESTIGATOR
The Korean Institute of Tuberculosis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Korean Institute of Tuberculosis
Osong, North Chungcheong, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KoreanTSTtrends
Identifier Type: -
Identifier Source: org_study_id